Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
---|
04/10/2003 | WO2003029199A1 Benzene derivatives, process for preparing the same and use thereof |
04/10/2003 | WO2003028728A1 4-(4-substituted piperazinyl-1yl)-butylcarboxamides as d3 dopamine subtype selective ligands |
04/10/2003 | WO2003028727A1 3-`hydroxy-(-4-trifluoromethylphenyl)-methyl-7-spirocyclobutyl-5,6,7,8-tetrahydroquinolin-5-ol derivatives and the use of the same as cholesterol ester transfer protein (cetp) inhibitors |
04/10/2003 | WO2003028726A1 Quinoline derivatives as neuropeptide y antagonists |
04/10/2003 | WO2003000175A3 Pediatric formulation of gatifloxacin |
04/10/2003 | WO2002094203A3 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
04/10/2003 | WO2002071827A3 Retinoid x receptor modulators |
04/10/2003 | WO2002060423A3 Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists |
04/10/2003 | WO2002018321A3 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
04/10/2003 | US20030069284 Anticancer agent |
04/10/2003 | US20030069271 Quinolone compounds for use in treating viral infections |
04/10/2003 | US20030069233 Central nervous system disorders; psychological disorders; Alzheimer's disease |
04/10/2003 | US20030069222 Used as anti-viral agents against the HIV-1 and HIV-2 viruses. |
04/10/2003 | CA2462030A1 3-`hydroxy-(-4-trifluoromethylphenyl)-methyl-7-spirocyclobutyl-5,6,7,8-tetrahydroquinolin-5-ol derivatives and the use of the same as cholesterol ester transfer protein (cetp) inhibitors |
04/10/2003 | CA2461686A1 Preparation of an anhydrous quinoline-based cetp inhibitor by crystallization |
04/10/2003 | CA2459868A1 Preparation of hiv protease inhibitors |
04/09/2003 | EP1299360A2 Heterocycle carboxamides as antiviral agents |
04/09/2003 | EP1299359A1 Chemical process for the extraction of 2-hydroxy pyridine derivatives, 2-hydroxyquinoline, and 2-hydroxybenzothiazole |
04/09/2003 | EP1299352A2 Compounds to treat alzheimer's disease |
04/09/2003 | EP1299349A2 Compounds to treat alzheimer's disease |
04/09/2003 | EP0928200B1 Therapeutic combinations of rar antagonists and rxr agonists |
04/09/2003 | EP0843663B1 4-aryl-thio-pyridin-2(1h)-ones, drugs containing same, and uses thereof for treating hiv-related diseases |
04/09/2003 | EP0708768B1 Tri-substituted imidazoles having multiple therapeutic properties |
04/09/2003 | CN1105114C Sulfonyl divalent aryl alpha-hydroxy-iso-hydroximic acid compounds |
04/09/2003 | CN1105107C Method of purifying quinaldine |
04/08/2003 | US6545155 Fused heteroaromatic glucokinase activators |
04/08/2003 | US6545018 Oxamic acids and derivatives as thyroid receptor ligands |
04/08/2003 | US6545015 Useful in therapy of bacterial infections, fungal infections |
04/08/2003 | US6545008 Pyrimidine derivatives and processes for the preparation thereof |
04/08/2003 | US6544990 Such as N-(4-chlorobenzyl)-8-(4-hydroxybut-1-ynyl)-1-methyl-6-(morpholin-4-ylmethyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide for treatment against herpes viruse; enzyme inhibitors |
04/08/2003 | CA2112165C Bicyclic amine derivatives |
04/08/2003 | CA2053216C Saturated hydroxyalkylquinoline acids as leukotriene antagonists |
04/04/2003 | WO2002030896A1 2,2-diphenylbutanamide derivatives and medicines containing the same |
04/04/2003 | CA2424979A1 2,2-diphenylbutanamide derivatives and medicines containing the same |
04/03/2003 | WO2003027132A2 METHOD OF PREPARING 17β-(N-TERT-BUTYLCARBAMOYL)-3-ONE STEROID DERIVATIVES |
04/03/2003 | WO2003027073A1 Process for producing optically active 7-{2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl}-3,5-dihydroxyhept-6-enoic acid ester |
04/03/2003 | WO2003026667A1 Quinazolino- and quinolino- guanidines as ligands for the neurop eptide ff (npff) receptors |
04/03/2003 | WO2003026659A1 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
04/03/2003 | US20030065187 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
04/03/2003 | US20030065018 Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
04/03/2003 | US20030065013 Central nervous system analgesic; hypotensive agents; antiarrhythmia agents; antidiabetic agents |
04/03/2003 | US20030065010 Preparation of anhydrous cetp inhibitor |
04/03/2003 | US20030064992 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
04/03/2003 | US20030064977 Viricides |
04/03/2003 | CA2688860A1 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
04/02/2003 | EP1296967A1 Quinolinyl and benzothiazolyl ppar-gamma modulators |
04/02/2003 | EP1296953A2 Methods and compounds for inhibiting mrp1 |
04/02/2003 | EP1296936A1 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
04/02/2003 | EP1296931A2 Polyamine analogues as cytotoxic agents |
04/02/2003 | EP1218345B1 Method of making metal 8-quinolinolato complexes |
04/02/2003 | CN1104422C Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
04/02/2003 | CN1104418C Benzoheterocyclic derivatives |
04/02/2003 | CN1104410C Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them |
04/01/2003 | US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis |
04/01/2003 | US6541661 Inhibitors of histone deacetylase |
04/01/2003 | US6541645 Electron-driven chirality switches |
04/01/2003 | US6541636 Such as 3-(2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolyl) prop-2-enenitrile by reacting 2-cyclopropyl-4-(4-fluorophenyl) quinoline-3-carbaldehyde with acetonitrile in the presence of base, then dehydrating; enzyme inhibitors |
04/01/2003 | US6541500 Fungicide mixture |
04/01/2003 | US6541498 Benzenesulfonamides and the use thereof to modulate the activity of endothelin |
04/01/2003 | US6541481 Substituted bicyclic derivatives useful as anticancer agents |
04/01/2003 | US6541477 Inhibitors of p38-a kinase |
04/01/2003 | US6541474 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia |
04/01/2003 | US6541470 Have a potent antiviral activity against picornaviruses and rotaviruses. |
03/31/2003 | WO2002030425A1 Preventives and remedies for complications of diabetes |
03/31/2003 | CA2424060A1 Preventives and remedies for complications of diabetes |
03/27/2003 | WO2003024955A2 Small molecule inhibitors of caspases |
03/27/2003 | WO2003024946A2 Oxamate derivatives containing a variously substituted nitrogen heterocycle |
03/27/2003 | WO2003024933A1 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same |
03/27/2003 | WO2003024899A2 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE) |
03/27/2003 | WO2003024448A2 Inhibitors of histone deacetylase |
03/27/2003 | WO2003024441A1 Novel use of tricyclic compound |
03/27/2003 | WO2003024395A2 Linked biaryl compounds |
03/27/2003 | WO2001092218A3 Polyamine analogues as therapeutic and diagnostic agents |
03/27/2003 | US20030060631 An amine substituent at the 7-position of the quinolone-carboxylic acid derivative is produced; bactericides |
03/27/2003 | US20030060474 A piperazine compound as antithrombotic agent |
03/27/2003 | US20030060461 Cyclic diamine compound with condensed-ring groups |
03/27/2003 | US20030060456 Such as 4-(2,3-dihydro-1-benzothien-5-yloxy)-3-((methylamino) methyl)-benzenesulfonamide for use as serotonin re-uptake inhibitors (SSRIs) in treatment of depression, attention deficit hyperactivity disorder, obsessive-compulsive disorder |
03/27/2003 | CA2465978A1 Inhibitors of histone deacetylase |
03/27/2003 | CA2460149A1 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same |
03/26/2003 | EP1296142A2 Calcium receptor active molecules |
03/26/2003 | EP1295514A2 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
03/26/2003 | EP1294694A2 Process for the preparation of quinoline derivatives |
03/26/2003 | EP1294366A1 Pharmaceutical compounds for treating copd |
03/26/2003 | EP1146873A4 Anti-androgens and methods for treating disease |
03/26/2003 | EP1105384B1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors |
03/26/2003 | EP0977748B1 Substituted benzopyran derivatives for the treatment of inflammation |
03/26/2003 | EP0801640B1 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same |
03/26/2003 | EP0793656B1 Novel benzyl pyrimidines |
03/26/2003 | CN1406225A Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists |
03/26/2003 | CN1405155A 5-chloro-8-hydroxyquinoline preparation method |
03/25/2003 | CA2379005A1 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
03/20/2003 | WO2003022810A1 3-amino carbonyl-substituted benzoylcyclohexanediones that can be used as herbicides |
03/20/2003 | WO2003022801A1 Reverse hydroxamic acid derivatives |
03/20/2003 | WO2003022785A2 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings |
03/20/2003 | WO2002067865A3 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
03/20/2003 | US20030055093 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
03/20/2003 | US20030055087 As analgesic |
03/20/2003 | US20030055086 Amino acid derivatives and use thereof as nep, ace and ece inhibitors |
03/20/2003 | US20030055077 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists |
03/20/2003 | US20030055071 For therapy, prophylaxis or delaying the onset of AIDS and infection by HIV |